BALTIMORE (WJZ) Researchers at the University of Maryland School of Medicine announced Thursday they have started testing the effectiveness of hydroxychloroquine as a therapy to prevent infection and symptoms in individuals who have been exposed to COVID-19-positive individuals.<\/p>\n
The research is part of a national study being conducted across the COVID-19 Therapeutics Accelerator.<\/p>\n
The goal of the research is to see if hydroxychloroquine can prevent people from becoming infected with SARS-CoV-2 and getting COVID-19\/coronavirus disease when taken by people who have had recent exposure to someone with the virus.<\/p>\n
CORONAVIRUS COVERAGE:<\/p>\n
The research is enrolling family members and frontline workers who have been exposed to individuals who have recently tested for the virus.<\/p>\n
The study is being conducted remotely through online video calls and by answering questions via email.<\/p>\n
Individuals who qualify for the randomized study will take either hydroxychloroquine or a placebo daily for 14 days.<\/p>\n
Volunteers who participate in the study will be asked to take the medication, complete an online survey to assess their symptoms and collect a sample by swabbing the inside of their nose every day for 14 days. On Day 28 a final swab will be collected and a survey completed.<\/p>\n
This study is a randomized, multi-center study, enrolling nationwide up to 2,000 men and women who meet the eligibility criteria. For more information click right here.<\/p>\n
For the latest information on coronavirus go to theMaryland Health Departments websiteor call 211. You can find all of WJZs coverage oncoronavirus in Maryland here.<\/p>\n
<\/p>\n
Follow this link:<\/p>\n
University Of Maryland School Of Medicine Test Experimental Therapy To Prevent COVID-19 - CBS Baltimore<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" BALTIMORE (WJZ) Researchers at the University of Maryland School of Medicine announced Thursday they have started testing the effectiveness of hydroxychloroquine as a therapy to prevent infection and symptoms in individuals who have been exposed to COVID-19-positive individuals. The research is part of a national study being conducted across the COVID-19 Therapeutics Accelerator. The goal of the research is to see if hydroxychloroquine can prevent people from becoming infected with SARS-CoV-2 and getting COVID-19\/coronavirus disease when taken by people who have had recent exposure to someone with the virus Continue reading